A Far UV-C Interview with Dr. David Brenner
As the world continues to grapple with the spread of infectious diseases, the need for effective, science-backed solutions to mitigate airborne transmission has never been greater. Ushio and Care222, pioneers in Far UV-C technology, sought to elevate awareness and credibility around their groundbreaking approach to pathogen reduction. To mark #222Day 2024, they needed a compelling way to engage key stakeholders, educate the public, and reinforce their leadership in the space. The challenge was to distill complex scientific insights into an accessible, high-impact conversation that would resonate across healthcare, technology, and public policy sectors.
The Next Practice designed and executed a strategic content initiative centered around an exclusive interview with Dr. David Brenner, the Director of the Center for Radiological Research at Columbia University and a leading authority on Far UV-C technology. This conversation served as the anchor for a broader multimedia rollout that included video storytelling, social media engagement, and targeted digital amplification.
By leveraging Dr. Brenner’s expertise and credibility, we ensured that the discussion remained scientifically rigorous while being accessible to a wide audience. The campaign was strategically timed for #222Day 2024 to maximize visibility, reinforcing Ushio and Care222’s position at the forefront of innovation in safe and effective airborne pathogen mitigation.